August 7, 2012
SPI's Pharmaceutical and Medical Device Applications Committee (PMDAC) gathered processors and material suppliers together last month to discuss requests coming from European customers for phthalate-free devices and components. The committee met with a group of legal and regulatory experts from Venable LLP to: evaluate "DEHP-free" and "phthalate-free claims; review existing precedence related to chemicals in toys and other products and discuss marketing guidance on products where phthalates are not intentionally added. The committee is now working on documenting professional guidance provided at this initial meeting and will solicit input from SPI members with experience in this area. By compiling this information, PMDAC plans to produce a useful document for members dealing with this or similar issues.
If you are interested in participating in PMDAC or more specifically in this document review, please contact SPI Staff.
Founded in 1937, SPI: The Plastics Industry Trade Association promotes growth in the $427 billion U.S. plastics industry. Representing nearly one million American workers in the third largest U.S. manufacturing industry, SPI delivers legislative and regulatory advocacy, market research, industry promotion and the fostering of business relationships and zero waste strategies. SPI also owns and produces the international NPE trade show. All profits from NPE are reinvested into SPI’s industry services. Find SPI online at www.plasticsindustry.org and www.inthehopper.org.
"From resin suppliers and equipment makers to processors and brand owners, SPI is proud to represent all facets of the U.S. plastics industry," said William R. Carteaux, president and CEO, SPI. "Our most recent economic reports show that the plastics industry as a whole is resilient, and has come through the recession significantly better than other U.S. manufacturing sectors."